ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1935

Skewed Escape from X-inactivation: Insights into the Female Bias of Sjögren’s Syndrome

Teressa Shaw1, Wei Zhang2, Sara McCoy3, Xueer Qiu1, Adam Pagenkopf1, Robert Hal Scofield4, Jacques Galipeau3 and Yun Liang1, 1University of Wisconsin-Madison, Madison, WI, 2University of California San Diego, La Jolla, CA, 3University of Wisconsin, Madison, WI, 4Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: ACR Convergence 2021

Keywords: autoimmune diseases, Epigenetics, Gene Expression, genomics, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Abstracts: Genetics, Genomics & Proteomics (1935–1938)

Session Type: Abstract Session

Session Time: 4:00PM-4:15PM

Background/Purpose: Many autoimmune diseases feature increased prevalence in females, with primary Sjögren’s syndrome (pSS) being the most female-predominant autoimmune disease with a female-to-male ratio of 14:1. Recent evidence suggests that the presence of two X chromosomes may underlie the female bias in pSS. However, the exact X chromosomal alterations on a single-gene level in pSS and their contribution to the female bias in pSS remain elusive. The objective of this study is to define the contribution of X-linked gene expression to pSS pathogenesis, focusing on minor salivary gland-derived mesenchymal stromal cells (MSCs) which are critical players maintaining salivary gland homeostasis.

Methods: Genome-wide, allele-specific expression profiling was performed using MSCs derived from female pSS subjects meeting 2016 ACR/EULAR criteria (n=4) and female control subjects with sicca symptoms but without clinical or laboratory features of autoimmunity (n=4). qRT-PCR of XIST (X-inactive-specific transcript) and quantitative immunostaining of H3K27me3 were performed to assess status of X-chromosome inactivation (XCI) in pSS and control MSCs. Protein localization was analyzed by quantitative immunofluorescence in pSS and control MSCs. Expression levels of IL4 were measured by qRT-PCR before and after MSC adipogenesis to assess the immunomodulatory properties of MSCs. Student’s t-test (two-sample, unequal variances) was used to compare experiment versus control groups for statistical significance.

Results: All pSS MSCs analyzed demonstrated marked skewing of X-linked genes that escape XCI (i.e. escapees), while all control MSCs exhibited balanced escapee expression (Fig. 1). Concomitantly, pSS MSCs showed decrease in XIST expression levels (P < 0.05) and reorganization of heterochromatic, silencing foci in the nucleus (P < 0.05), suggesting a global disruption in XCI maintenance (Fig. 2). The skewing in X-inactivation escape in pSS MSCs was accompanied by mislocalization of protein products encoded by the escapees as well as inflammatory differentiation of MSCs (P < 0.05), consistent with the hallmark features of inflammation and fibrosis in pSS salivary glands (Fig. 3).

Conclusion: We discovered global skewing of X-linked genes in pSS but not control MSCs, and identified escapee skewing as a new mechanism underlying pSS pathogenesis. Given that XCI is a female-specific process, our data suggests that dysregulation of XCI escape contributes to the female bias in pSS.

Figure 1. pSS MSCs demonstrate marked X skewing. Allele-specific transcriptomic profiling of control (N1 – N4) and pSS (SS1 – SS4) female MSCs, showing MAF (minor allele frequency) of heterozygous common SNPs on each chromosome. MAF of ~0.5 suggests equal contribution from maternal and paternal alleles, while MAF < 0.4 suggests skewing. For each sample, MAFs are shown for each chromosome (chromosomes 1_22, X; from left to right), with arrows pointing to MAFs on chromosome X (black for control, red for pSS).

Figure 2. pSS MSCs exhibit XCI defects. A, qRT-PCR of XIST expression levels in control (N) and pSS (SS) MSCs. B, quantification of cells with 0, 1, and 2 H3K27me3+ nuclear foci in control (N) and pSS (SS) MSCs. C, immunofluorescence images of H3K27me3 and DAPI staining of control (N) and pSS (SS) MSCs, with arrows pointing to pSS cells with ectopic H3K27me3+ foci. Mean ± sem, * P < 0.05, two-tailed Student’s t-test.

Figure 3. Escapee skewing in pSS MSCs is accompanied by escapee protein mislocalization and MSC inflammatory differentiation. A, immunostaining of a representative escapee, CHST, in control (N) and pSS (SS) MSCs. Arrow points to CHST+ nuclear foci that are absent in pSS MSCs. B, quantitative nuclear foci analysis in control (N) and pSS (SS) MSCs. C, qRT-PCR of IL4 in undifferentiated (Undiff) and differentiated (Diff) control (N) and pSS (SS) MSCs. Mean ± sem, * P < 0.05, two-tailed Student’s t-test.


Disclosures: T. Shaw, None; W. Zhang, Bristol Myers Squibb, 3, Goldfinch Bio, Inc., 3; S. McCoy, BMS, 2, Novartis, 1, Boehringer Ingelheim, 6; X. Qiu, None; A. Pagenkopf, None; R. Scofield, None; J. Galipeau, CAMBIUM MEDICAL TECHNOLOGIES, 8; Y. Liang, None.

To cite this abstract in AMA style:

Shaw T, Zhang W, McCoy S, Qiu X, Pagenkopf A, Scofield R, Galipeau J, Liang Y. Skewed Escape from X-inactivation: Insights into the Female Bias of Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/skewed-escape-from-x-inactivation-insights-into-the-female-bias-of-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/skewed-escape-from-x-inactivation-insights-into-the-female-bias-of-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology